Exhibit 23.1 Consent of Ernst & Young

We consent to the reference to our firm under the caption “Experts” in this Form S-3 Registration Statement and related Prospectus of Lexicon Pharmaceuticals, Inc. for the registration of 13,237,519 shares of its common stock and to the incorporation by reference therein of our reports dated March 7, 2012, with respect to the consolidated financial statements of Lexicon Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Lexicon Pharmaceuticals, Inc., included in its Annual Report (Form 10‑K) for the year ended December 31, 2011, filed with the Securities and Exchange Commission.